A detailed history of Stem Point Capital LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 942,857 shares of TARA stock, worth $2.16 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
942,857
Previous 984,113 4.19%
Holding current value
$2.16 Million
Previous $2.05 Billion 15.71%
% of portfolio
0.52%
Previous 0.6%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.7 - $2.4 $70,135 - $99,014
-41,256 Reduced 4.19%
942,857 $1.73 Billion
Q2 2024

Aug 13, 2024

BUY
$1.96 - $4.14 $1.6 Million - $3.38 Million
815,671 Added 484.24%
984,113 $2.05 Billion
Q1 2024

May 13, 2024

BUY
$1.86 - $4.83 $313,302 - $813,574
168,442 New
168,442 $675 Million

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $25.8M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.